Estrella Immunopharma, Inc.
ESLA
$0.7936
-$0.0428-5.12%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.80M | 4.17M | 4.73M | 9.05M | 22.14M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 437.60K | 288.80K | 3.91M | 401.20K | 138.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 5.07M |
| Total Current Assets | 2.24M | 4.45M | 8.63M | 9.45M | 27.35M |
|
|
|||||
| Total Current Assets | 2.24M | 4.45M | 8.63M | 9.45M | 27.35M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.50M | -- | -- | -- | -- |
| Total Assets | 3.74M | 4.45M | 8.63M | 9.45M | 27.35M |
|
|
|||||
| Total Accounts Payable | 5.00K | -- | -- | 77.10K | 9.34M |
| Total Accrued Expenses | 2.94M | 135.60K | 93.40K | 4.40K | 2.51M |
| Short-term Debt | -- | -- | -- | -- | 300.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.00K | 4.00K | 4.00K | 6.00K | 24.00K |
| Total Finance Division Other Current Liabilities | 43.60K | 41.10K | 41.10K | 311.30K | 5.11M |
| Total Other Current Liabilities | 43.60K | 41.10K | 41.10K | 311.30K | 5.11M |
| Total Current Liabilities | 2.99M | 180.70K | 138.50K | 398.70K | 17.28M |
|
|
|||||
| Total Current Liabilities | 2.99M | 180.70K | 138.50K | 398.70K | 17.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 300.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.99M | 180.70K | 138.50K | 398.70K | 17.28M |
|
|
|||||
| Common Stock & APIC | 24.13M | 24.13M | 24.13M | 24.13M | 24.13M |
| Retained Earnings | -22.88M | -19.50M | -15.55M | -15.08M | -14.06M |
| Treasury Stock & Other | -504.90K | -354.40K | -84.10K | -- | -- |
| Total Common Equity | 746.30K | 4.27M | 8.49M | 9.05M | 10.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 746.30K | 4.27M | 8.49M | 9.05M | 10.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 746.30K | 4.27M | 8.49M | 9.05M | 10.07M |
|
|
|||||